scholarly journals Vulvar intraepithelial neoplasia (VIN2/3): Comparing clinical outcomes and evaluating risk factors for recurrence

2012 ◽  
Vol 125 ◽  
pp. S82 ◽  
Author(s):  
J. Wallbillich ◽  
H. Rhodes ◽  
A. Milbourne ◽  
M. Munsell ◽  
M. Frumovitz ◽  
...  
2012 ◽  
Vol 127 (2) ◽  
pp. 312-315 ◽  
Author(s):  
J.J. Wallbillich ◽  
H.E. Rhodes ◽  
A.M. Milbourne ◽  
M.F. Munsell ◽  
M. Frumovitz ◽  
...  

2018 ◽  
Vol 148 (1) ◽  
pp. 126-131 ◽  
Author(s):  
W. Satmary ◽  
C.H. Holschneider ◽  
L.L. Brunette ◽  
S. Natarajan

Cancers ◽  
2022 ◽  
Vol 14 (2) ◽  
pp. 389
Author(s):  
Lauro Bucchi ◽  
Margherita Pizzato ◽  
Stefano Rosso ◽  
Stefano Ferretti

The aim of this review was an update of vulvar cancer incidence rates and trends and of all known and putative risk factors for the disease. The most recent incidence data were sought from official sources (WHO Cancer Incidence in Five Continents). To obtain an estimate of time trends in some areas, we compared data from Cancer Incidence in Five Continents with the few available studies that measured incidence using comparable methods. With respect to risk factors, a systematic PubMed search identified 1585 relevant articles published between 1980 and 2021. Abstracts and full texts were screened. Sixty-nine eligible original cohort and case-control studies were selected. Information was extracted using a PRISMA predesigned form. Nineteen risk factors, or risk factor categories, were investigated by two or more original studies. Solitary, unreplicated studies addressed the putative role of eight more factors. Recent advances have provided further evidence supporting the carcinogenic model centred on human papillomavirus infection with different defects of the immune function. Conversely, the model centred on the role of vulvar lichen sclerosus and the often associated differentiated vulvar intraepithelial neoplasia has continued to be epidemiologically understudied. More research on the association between these two conditions and vulvar cancer is a priority.


2009 ◽  
Vol 41 (3) ◽  
pp. 196-202 ◽  
Author(s):  
Hee Seung Kim ◽  
Noh Hyun Park ◽  
In-Ae Park ◽  
Ju Hee Park ◽  
Hyun Hoon Chung ◽  
...  

2017 ◽  
Vol 127 (5) ◽  
pp. 1117-1125 ◽  
Author(s):  
Myung-Hoon Han ◽  
Je il Ryu ◽  
Choong Hyun Kim ◽  
Jae Min Kim ◽  
Jin Hwan Cheong ◽  
...  

OBJECTIVEChronic subdural hematoma (CSDH) is a common type of intracranial hemorrhage in elderly patients. Many studies have suggested various factors that may be associated with the recurrence of CSDH. However, the results are inconsistent. The purpose of this study was to determine the associations among patient factors, recurrence, and clinical outcomes of CSDH after bur hole surgery performed during an 11-year period at twin hospitals.METHODSKaplan-Meier analysis was performed to evaluate the risk factors for CSDH recurrence. Univariate and multivariate Cox proportional hazards regression analyses were used to calculate hazard ratios with 95% CIs for CSDH recurrence based on many variables. One-way repeated-measures ANOVA was used to assess the differences in the mean modified Rankin Scale score between categories for each risk factor during each admission and at the last follow-up.RESULTSThis study was a retrospective analysis of 756 consecutive patients with CSDH who underwent bur hole surgery at the Hanyang University Medical Center (Seoul and Guri) between January 1, 2004, and December 31, 2014. During the 6-month follow-up, 104 patients (13.8%) with recurrence after surgery for CSDH were identified. Independent risk factors for recurrence were as follows: age > 75 years (HR 1.72, 95% CI 1.03–2.88; p = 0.039), obesity (body mass index ≥ 25.0 kg/m2), and a bilateral operation.CONCLUSIONSThis study determined the risk factors for recurrence of CSDH and their effects on outcomes. Further studies are needed to account for these observations and to determine their underlying mechanisms.


Sign in / Sign up

Export Citation Format

Share Document